Literature DB >> 7665587

Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry.

J Jirácek1, A Yiotakis, B Vincent, A Lecoq, A Nicolaou, F Checler, V Dive.   

Abstract

Several hundred phosphinic peptides having the general formula Z-(L,D)Phe psi (PO2CH2)(L,D)Xaa'-Yaa'-Zaa', where Xaa' = Gly or Ala and Yaa' and Zaa' represent 20 different amino acids, have been synthesized by the combinatorial chemistry approach. Peptide mixtures or individual peptides were evaluated for their ability to inhibit the rat brain zinc endopeptidases 24-15 and 24-16. Numerous phosphinic peptides of this series act as potent (Ki in the nanomolar range) mixed inhibitors of these two peptidases. However, our systematic and comparative strategy led us to delineate the residues located in P2' and P3' positions of the inhibitors that are preferred by these two peptidases. Thus, endopeptidase 24-15 exhibits a marked preference for inhibitors containing a basic residue (Arg or Lys) in the P2' position, while 24-16 prefers a proline in this position. The P3' position has less influence on the inhibitory potency and selectivity, both peptidases preferring a hydrophobic residue at this position. On the basis of these observations, we have prepared highly potent and selective inhibitors of endopeptidase 24-15. The Z-(L,D)Phe psi-(PO2CH2)(L,D)Ala-Arg-Met compound (mixture of the four diastereoisomers) displays a Ki value of 70 pM for endopeptidase 24-15. The most selective inhibitor of endopeptidase 24-15 in this series, Z-(L,D)Phe psi (PO2-CH2)(L,D)Ala-Arg-Phe, exhibits a Ki value of 0.160 nM and is more than 3 orders of magnitude less potent toward endopeptidase 24-16 (Ki = 530 nM). Furthermore, at 1 microM this selective inhibitor is unable to affect the activity of several other zinc peptidases, namely endopeptidase 24-11, angiotensin-converting enzyme, aminopeptidase M, leucine aminopeptidase, and carboxypeptidases A and B. Therefore, Z-(L,D)Phe psi (PO2CH2)(L,D)Ala-Arg-Phe can be considered as the most potent and specific inhibitor of endopeptidase 24-15 developed to date. This new inhibitor should be useful in assessing the contribution of this proteolytic activity in the physiological inactivation of neuropeptides known to be hydrolyzed, at least in vitro, by endopeptidase 24-15. Our study also demonstrates that the combinatorial chemistry approach leading to the development of phosphinic peptide libraries is a powerful strategy for discovering highly potent and selective inhibitors of zinc metalloproteases and should find a broader application in studies of this important class of enzymes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665587     DOI: 10.1074/jbc.270.37.21701

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15.

Authors:  C N Shrimpton; G Abbenante; R A Lew; I Smith
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

2.  Discovery of a herbicidal lead using polymer-bound activated esters in generating a combinatorial library of amides and esters.

Authors:  J J Parlow; J E Normansell
Journal:  Mol Divers       Date:  1996-08       Impact factor: 2.943

Review 3.  Discovery of enzyme inhibitors through combinatorial chemistry.

Authors:  R E Dolle
Journal:  Mol Divers       Date:  1997       Impact factor: 2.943

4.  Allosteric inhibition of the neuropeptidase neurolysin.

Authors:  Christina S Hines; Kallol Ray; Jack J Schmidt; Fei Xiong; Rolf W Feenstra; Mia Pras-Raves; Jan Peter de Moes; Jos H M Lange; Manana Melikishvili; Michael G Fried; Paul Mortenson; Michael Charlton; Yogendra Patel; Stephen M Courtney; Chris G Kruse; David W Rodgers
Journal:  J Biol Chem       Date:  2014-11-05       Impact factor: 5.157

5.  Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1.

Authors:  Mirian A F Hayashi; Fernanda C V Portaro; Marta F Bastos; Juliano R Guerreiro; Vitor Oliveira; Silvia S Gorrão; Denise V Tambourgi; Osvaldo A Sant'Anna; Paul J Whiting; L Miguel Camargo; Katsuhiro Konno; Nicholas J Brandon; Antonio C M Camargo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-23       Impact factor: 11.205

6.  RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites.

Authors:  V Dive; J Cotton; A Yiotakis; A Michaud; S Vassiliou; J Jiracek; G Vazeux; M T Chauvet; P Cuniasse; P Corvol
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

7.  The exquisite structure and reaction mechanism of bacterial Pz-peptidase A toward collagenous peptides: X-ray crystallographic structure analysis of PZ-peptidase a reveals differences from mammalian thimet oligopeptidase.

Authors:  Akio Kawasaki; Hiroaki Nakano; Allin Hosokawa; Toru Nakatsu; Hiroaki Kato; Kunihiko Watanabe
Journal:  J Biol Chem       Date:  2010-09-03       Impact factor: 5.157

8.  Phosphinic peptides, the first potent inhibitors of astacin, behave as extremely slow-binding inhibitors.

Authors:  I Yiallouros; S Vassiliou; A Yiotakis; R Zwilling; W Stöcker; V Dive
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

9.  Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.

Authors:  R A Lew; F Tomoda; R G Evans; L Lakat; J H Boublik; L A Pipolo; A I Smith
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

10.  Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases.

Authors:  Stamatia Vassiliou; Ewelina Węglarz-Tomczak; Łukasz Berlicki; Małgorzata Pawełczak; Bogusław Nocek; Rory Mulligan; Andrzej Joachimiak; Artur Mucha
Journal:  J Med Chem       Date:  2014-09-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.